[On combined conservative therapy of acute pancreatitis].
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D001337:Autonomic Agents / Q000627:therapeutic use; D001340:Autonomic Nerve Block; D004791:Enzyme Inhibitors; D005730:Ganglionic Blockers / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000150:complications / Q000188:drug therapy; D007674:Kidney Diseases / Q000628:therapy; D008107:Liver Diseases / Q000150:complications / Q000188:drug therapy; D046911:Macromolecular Substances / Q000627:therapeutic use; D009020:Morphine / Q000627:therapeutic use; D009132:Muscles / Q000627:therapeutic use; D009573:Nitrites / Q000627:therapeutic use; D010195:Pancreatitis / Q000150:complications / Q000628:therapy*; D010477:Perfusion; D010880:Piperidines / Q000627:therapeutic use; D010952:Plasma Substitutes / Q000627:therapeutic use; D011343:Procaine / Q000627:therapeutic use; D012965:Sodium Chloride / Q000627:therapeutic use; D012996:Solutions
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D000900:Anti-Bacterial Agents; D001337:Autonomic Agents; D004791:Enzyme Inhibitors; D005730:Ganglionic Blockers; D006634:Histamine H1 Antagonists; D046911:Macromolecular Substances; D009573:Nitrites; D010880:Piperidines; D010952:Plasma Substitutes; D012996:Solutions; D012965:Sodium Chloride; D011343:Procaine; D009020:Morphine; D001285:Atropine; D005947:Glucose
K komplekse konservativnoĭ terapii ostrogo pankreatita.